| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
16,254 |
1,263 |
$440K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
15,537 |
767 |
$36K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
6,445 |
518 |
$12K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,297 |
513 |
$4K |
| 85048 |
|
578 |
550 |
$0.00 |
| 85041 |
|
577 |
549 |
$0.00 |
| 83970 |
|
365 |
353 |
$0.00 |
| 83540 |
|
202 |
197 |
$0.00 |
| 82108 |
|
51 |
49 |
$0.00 |
| 83550 |
|
217 |
212 |
$0.00 |
| A4657 |
Syringe, with or without needle, each |
776 |
682 |
$0.00 |
| 82728 |
|
226 |
221 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
75 |
46 |
$0.00 |
| 82607 |
|
49 |
48 |
$0.00 |
| 82306 |
|
50 |
47 |
$0.00 |
| 90674 |
|
13 |
13 |
$0.00 |